Development of Dual-Targeted Nano-Dandelion Based on an Oligomeric Hyaluronic Acid Polymer Targeting Tumor-Associated Macrophages for Combination Therapy of Non-Small Cell Lung Cancer

Drug Delivery - United Kingdom
doi 10.1080/10717544.2019.1693707
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

663. Targeting Tumor-Associated Macrophages for Cancer Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

A Decade of Targeted Therapy for Non-Small Cell Lung Cancer

2017English

Targeted Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Recent Advances in Targeted Small-Molecule Inhibitor Therapy for Non-Small-Cell Lung Cancer-An Update

Journal of Clinical Pharmacy and Therapeutics
Pharmacology
2020English

The M1 Form of Tumor-Associated Macrophages in Non-Small Cell Lung Cancer Is Positively Associated With Survival Time

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non–Small Cell Lung Cancer

Cancer Research
Cancer ResearchOncology
2017English

Correction to “Tumor Targeting and Lipid Rafts Disrupting Hyaluronic Acid-Cyclodextrin-Based Nanoassembled Structure for Cancer Therapy”

ACS Applied Materials & Interfaces
MedicineMaterials ScienceNanotechnologyNanoscience
2018English

Commentary on “Gemcitabine: Single‐Agent and Combination Therapy in Non‐Small Cell Lung Cancer”

Oncologist
Cancer ResearchMedicineOncology
1999English

Small Cell Lung Cancer: Recruitment of Macrophages by Circulating Tumor Cells

OncoImmunology
OncologyAllergyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy